BSE filing, NSE: INDOUS. Summary written from the filing by ALFA Finder's alert engine.
Indo US Bio-Tech Ltd: key numbers
- Share price
- ₹78.36
- Market cap
- ₹157.1 Cr
- Revenue (annual)
- ₹110.4 Cr
- Net profit (annual)
- ₹13.12 Cr
- P/E (TTM)
- 13.7×Sector 27.1×
- Promoter holding
- 68.29%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indo US Bio-Tech Ltd
All →Indo US Bio-Tech Board Meeting Date
Indo Us Bio-Tech has intimated that its board will meet on 30 October 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The notice is advance intimation only, with no results yet reported.
Indo US Bio-Tech Business Update
Indo Us Bio-Tech disclosed promoter invitations to attend China's 140th Canton Fair. The filing states no financial value or business commitment.
Indo US Bio-Tech Annual General Meeting
Indo Us Bio-Tech Limited held its 22nd Annual General Meeting on September 30, 2026. The filing provides a gist of the meeting's proceedings and agenda items.
Indo US Bio-Tech Annual Report
Indo Us Bio-Tech Ltd submitted its Annual Report for FY 2025-2026. The 22nd Annual General Meeting is scheduled for September 30, 2026.
Indo US Bio-Tech Annual General Meeting
Indo Us Bio-Tech Limited has issued a notice for its 22nd Annual General Meeting, scheduled for September 30, 2026, to be conducted via video conferencing.
Indo US Bio-Tech Board Meeting Outcome
Indo Us Bio-Tech Ltd announced outcomes of its board meeting, including the date for its 22nd AGM and appointment of statutory auditors.
Other other announcement announcements
All →STL Networks Other Announcement
The Monitoring Agency reported Rs. 2 Crore utilization of Preferential Issue proceeds, with no deviations from objects. The report covers the quarter ending September 30, 2026.
HEG Advanced Materials Other Announcement
HEG Advanced Materials Limited has intimated the exchange regarding the change of its Corporate Identification Number (CIN) following an approved scheme of arrangement.
Sanofi India Other Announcement
Sanofi India issued a communication regarding Tax Deduction at Source (TDS) for the interim dividend declared for FY 2026. Shareholders must update details by November 5, 2026.
Visaka Industries Other Announcement
Visaka Industries informed the exchange about sending reminder letters to shareholders regarding the compulsory transfer of unclaimed dividends and equity shares to the IEPF account.
Arvaya Healthcare Other Announcement
Arvaya Healthcare filed its quarterly shareholding pattern under Regulation 31(1)(c). The filing reports routine ownership breakdowns with no transaction.
AYM Syntex Other Announcement
AYM Syntex's board appointed BSR & Co. LLP as statutory auditor for five years, subject to shareholder approval. Routine auditor appointment; no monetary value involved.
- Execution
- Five consecutive years, from the conclusion of the 44th AGM to the conclusion of the 49th AGM